The urgent need for new HIV/STD prevention options for women

Journal of Women's Health

Volumn 7, Issue 9, 1998, Pages 1081-1086

  Irwin, Kathleen ^a,b,c   Scarlett, Margaret ^a,c   Moseley, Robin ^a,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Division of HIV/AIDS Prevention   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NONOXINOL 9; AGENTS USED INTRAVAGINALLY; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CHLAMYDIASIS; CLINICAL TRIAL; CONDOM; FEMALE; FEMALE GENITAL TRACT INFLAMMATION; GENITAL ULCER; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVAGINAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; FINANCIAL MANAGEMENT; HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH SERVICE; REVIEW; UNITED STATES;

ANTI-INFECTIVE AGENTS, LOCAL; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CONDOMS, FEMALE; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; PRIVATE SECTOR; PUBLIC SECTOR; RESEARCH SUPPORT; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0032200914     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.1081     Document Type: Article

References (27)

1. Joint United Nations Programme on HIV/AIDS and the World Health Organization. Report on the Global HIV/AIDS Epidemic, Number UNAIDS 98.10. Geneva: World Health Organization, 1998.
2. National Center for Health Statistics. Health-United States 1996-1997 and Injury Chartbook. DHHS Public. No. PHS 97-1232. Hyattsville, MD: Superintendent of Documents, 1997:243.
3. Eng TR, Butler WT, eds. The hidden epidemic: Confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997:28.
4. United States Public Health Service. Surgeon General's report on AIDS. Washington, DC: Superintendent of Documents, 1985.
5. Warner DL, Hatcher RA. Male condoms. In: Hatcher RA, Stewart FA, Stewart GK, et al., eds. Contraceptive technology, 17th ed. New York: Irvington Publishers, 1998:325.
6. Riccinino LJ, Mosure WD. Trends in contraceptive use. Family Planning Perspectives 1998;30:4.
7. Centers for Disease Control and Prevention. Trends in sexual risk behaviors among high school students -United States, 1991-1997. MMWR 1998;47:749.
8. du Guerny J, Sjoberg E. Inter-relationship between gender relations and the HIV/AIDS epidemic: Some possible considerations for policies and programmes [Editorial]. AIDS 1993;7:1027.
9. Stanley S, Minkoff H. Infectious disease and emerging infections. In: Beyond Hunt Valley: Research on women's health for the 21st century. Bethesda, MD: Office of Research on Women's Health, National Institutes of Health, 1998:45.
10. Stewart FA. Vaginal barriers. In: Hatcher RA, Stewart FA, Stewart GK, et al., eds. Contraceptive technology, 17th ed. New York: Irvington Publishers, 1998:371.
11. Fontanet AL, Saba J, Chandelying V, et al. Increased protection against sexually transmitted diseases by giving commercial sex workers in Thailand the choice of using the male or female condom: A randomised controlled trial. AIDS. In press.
12. Centers for Disease Control and Prevention. Update: Barrier protection against HIV infection and other sexually transmitted diseases. MMWR 1993;42:589.
13. World Health Organization. The female condom: A review. Geneva: World Health Organization, 1997.
14. Watts C, Thompson W, Heise L. The effectiveness of microbicides for HIV prevention. Presented at the 12th International Conference on AIDS, Geneva, June 28-July 3, 1998. Abstract 33161.
15. Hillmark International Business Consultants. Media briefing of the European Union Global Marketing Survey on Microbicides. Presented at the 12th International Conference on AIDS, Geneva, June 28-July 3, 1998.
16. Elias CJ, Coggins C. Female controlled methods to prevent sexual transmission of HIV/AIDS. AIDS 1996; 10(Suppl 3):S43.
17. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol 9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518.
18. AIDS Institute, New York State Department of Health. Sexually transmitted HIV infection and women: Methods of personal protection. Albany, NY: New York State Department of Health, 1992.
19. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992;268:477.
20. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339:504.
21. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomised controlled trial. Lancet 1995;346:530.
22. Van Damme L, Chandeying V, Ramjee, et al. Safety of multiple daily applications of COL-1492, a nonoxynol 9 vaginal gel, among female sex workers. Presented at the 12th International Conference on AIDS, Geneva, June 28-July 3, 1998. Abstract 33145.
23. Heise L. McGrory E, Wood S. Practical and ethical dilemmas in the clinical testing of microbicides: A report on a symposium. New York: International Women's Health Coalition, New York, 1988.
24. Alliance for Microbicide Development. Microbicides: Research and development status, September 1998. Tacoma Park, MD: Alliance for Microbicide Development, 1998.
25. Medical Research Council. Survey of industrial interests, attitudes, and perceptions of the development of vaginal viracides to prevent heterosexual transmission of HIV. London: Medical Research Council, 1997.
26. Contraceptive Research and Development (CONRAD) Program. 1997 Annual Report: Making progress toward more effective, safe, and acceptable contraceptives. Arlington, VA: CONRAD, 1997.
27. National Institute of Allergy and Infectious Diseases. Topical Microbicides Program. Proceedings of a preclinical evaluation workshop, May 20-21, 1998. Bethesda, MD: National Institute of Allergy and Infectious Diseases, 1998.